单位:[1]Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430000, China.[2]Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.内科学系风湿免疫内科华中科技大学同济医学院附属同济医院[3]Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.外科学系整形美容外科华中科技大学同济医学院附属同济医院[4]Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310000, China.
第一作者单位:[1]Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430000, China.[2]Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Gao Rongfen,Wu Yumin,Yang Qian,et al.The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGFβ-Induced Endothelial-to-Mesenchymal Transition[J].Oxidative medicine and cellular longevity.2023,2023:5012474.doi:10.1155/2023/5012474.
APA:
Gao Rongfen,Wu Yumin,Yang Qian,Chen Liangdong,Chen Jiwei...&Wu Gaosong.(2023).The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGFβ-Induced Endothelial-to-Mesenchymal Transition.Oxidative medicine and cellular longevity,2023,
MLA:
Gao Rongfen,et al."The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGFβ-Induced Endothelial-to-Mesenchymal Transition".Oxidative medicine and cellular longevity 2023.(2023):5012474